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Abstract 
 
Cancer cells often exhibit loss of functional tight junctions (TJs), and disruption of the TJ 
structure is associated with cancer development.  However, whether loss of a certain type of 
claudin, an integral membrane protein of TJs, is involved in malignant phenotypes remains to 
be clarified.  Based on the report that claudin-6 functions as a tumor suppressor for breast 
cancer, we show here that suppression of claudin-6 expression results in increased resistance 
to various apoptogens, and causally enhances anchorage-independent growth properties.  
Since claudin-6 expression is partially silenced by promoter CpG island hypermethylation in 
MCF7 breast carcinoma cells, a synergistic effect of a demethylator and histone deacetylase 
inhibitor upregulates the expression of endogenous claudin-6, which is sufficient for 
apoptotic sensitization and abrogation of colony-forming efficacy.  In addition, decreased 
expression of claudin-6 promotes cellular invasiveness and transendothelial migration, 
accompanied by an increase in matrix metalloproteinase activity.  These data suggest that the 
methylator phenotype of claudin-6 may at least partially contribute to enhanced tumorigenic 
and invasive properties of breast carcinoma cells. 
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Introduction 
 
 Tight junctions (TJs) are intercellular structures in epithelial and endothelial cells, 
primarily playing a critical role in cell-cell adhesion.(1,2)  Recent evidence has revealed that 
TJs are directly involved in the regulation of cellular functions such as proliferation, 
differentiation, and apoptosis, due to the ability of TJ proteins to recruit various signaling 
molecules that have proliferative and differentiative capacities, including transcription factors, 
lipid phosphatases, and cell cycle regulators.(1-3)  While one of the first identified TJ-
associated molecules was occludin,(4,5) claudins, of which there are at least 24, have been 
shown to be the main constituents as integral membrane proteins of TJs.(1,2) 
 A growing body of evidence has demonstrated that cancer cells, particularly in those 
tumors that manifest high metastatic potential, often exhibit loss of functional TJs.(6)  
Disruption of the TJ structure has been shown to be associated with cancer development, 
which may be causally involved in malignant phenotypes such as local tumor growth, 
invasion, and metastasis at distant sites.(6-8)  We have also demonstrated that epigenetic 
silencing of occludin contributes to enhanced tumorigenicity of cancer cells.(9,10)  In parallel, 
decreased and/or impaired TJ formation has been reported for various types of cancer, and 
genes having an oncogenic character are known to disrupt TJs.(11,12)  In addition, a number of 
immunohistochemical studies showed reduced expression of claudins in a variety of cancer 
tissues.(11,13,14)  Many members of the claudin family show a distinct organ-specific 
distribution of such expression and are abnormally regulated in several human cancers; 
however, the functional roles of claudins in cancer cells have not been clearly defined. 
 Based on the finding that claudin-6 is preferentially expressed in mammary epithelial 
cells and functions as a tumor suppressor for breast cancer,(15)  we examined whether loss of 
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claudin-6 had any effect on MCF7 breast carcinoma cells.  Herein, we clearly show that the 
knockdown of endogenous claudin-6 in MCF7 cells resulted in increased resistance to a 
number of differently acting apoptogens, and causally enhanced anchorage-independent 
growth.  These findings support our plausible hypothesis that the decreased expression of 
claudin-6 may at least partially contribute to enhanced tumorigenicity of breast carcinoma 
cells. 
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Materials and Methods 
 
Cell line and transfection.  MCF7, a human breast carcinoma cell line, was maintained in 
DMEM (Invitrogen, Carlsbad, CA) supplemented with 10% FBS (Sanko Jyunyaku, Tokyo, 
Japan), 10 mM HEPES, 100 U/ml penicillin, and 100 g/ml streptomycin.  Claudin-6-
specific small interfering RNA (siRNA, 10 nM as a default concentration in the dose range of 
10-100 nM; QIAGEN, Tokyo, Japan) was transfected into the cells 48 h before apoptotic 
stimulation, using FuGENE 6 (Roche, Indianapolis, IN).  Negative control siRNA (Santa 
Cruz Biotechnologies, Santa Cruz, CA) was also transfected.  siRNA-mediated suppression 
of claudin-6 expression was confirmed by quantitative reverse transcription (RT)-PCR and 
western blot analysis. 
 
Cell death analyses.  Apoptosis was stimulated with oxidative stress using H2O2 (Sigma, 
Tokyo, Japan) in the dose range from 0 to 100 M with cells treated for 1 h to 24 h, and 
various death-inducing agents, including heat shock at 42C for 30 min, etoposide (50 M), 
cisplatin (10 g/ml), and -irradiation (100 Gy).  Anoikis was induced by preventing cells 
from adhering to the cell culture dishes.(9)  In some experiments, cells were transfected with 
or without claudin-6-specific siRNA in the presence or absence of all-trans retinoic acid 
(atRA, 100 nM, Sigma), which is an apoptotic sensitizer.(16)  To examine the effect of a 
demethylating agent, the cells were treated with 5’-aza-2’deoxycytidine (5’Aza-dC, 1 M as 
a default concentration in the dose range from 0-5 M, Sigma) for 48 h, after which a histone 
deacetylase inhibitor (HDAI) or trichostatin A (TSA, 100 nM as a default concentration in 
the dose range from 0-300 nM, Sigma) was added, followed by incubation for an additional 
24 h at 37C.  Apoptotic cell death was evaluated as described.(9,16)  Briefly, total cells in the 
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tissue culture wells were harvested, and resuspended in lysis buffer containing 10 mM Tris-
HCl (pH 8.0), 10 mM EDTA, and 0.5% Triton X-100 for 15 min at 4C.  The cells were then 
centrifuged at 12,000 xg for 20 min at 4C to separate intact chromatin in the pellet from 
DNA fragments in the supernatant that preferentially contained low molecular weight cellular 
DNA.(9)  The DNA amounts in each pellet and supernatant were determined using a 
diphenylamine reagent and the fragmentation rate (%) was expressed as (fragmented DNA / 
total DNA) x 100.  DNA samples were also electrophoresed on 2.5% agarose gels to show 
the ladder formation due to nuclear fragmentation.  To confirm the quantitativeness of cell 
death, we also performed the terminal deoxynucleotidyl transferase-mediated nick end 
labeling (TUNEL) assay using an In Situ Cell Death Detection Kit (Roche).  The positive 
cells were scored using light microscopy by counting the number of cells under low 
magnification (x 100) in 10 separate arbitrarily selected fields in each section.   
 
Quantitative RT-PCR analysis.  Total RNA (1 g) extracted by TRIzol (Invitrogen) was 
reverse-transcribed using M-MuLV reverse transcriptase (Applied Biosystems, Foster City, 
CA).  For analysis of gene expression, the gene of interest was amplified from dilutions of 
cDNA using specific sense and antisense primers for up to 40 cycles, and we examined 
various cycling parameters for each PCR experiment to define optimal conditions for 
linearity to allow for quantitative analysis of signal intensity.  Triplicate independent PCR 
reactions were carried out to ensure the reproducibility of expression quantification.  For the 
densitometric analysis, signals were quantitated using Scion Image 1.62 (Scion Corporation, 
Frederick, MD).  Oligonucleotide sequences of all primers used for the PCR reactions are 
available on request. 
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Colony forming assay in two- and three-dimensional cultures.  To assess a colony 
forming efficacy, cells (5 x 105 cells/well) transfected with or without claudin-6-specific 
siRNA were plated on 6-well plates 24 h prior to exposure to a lethal dose of -irradiation 
(>100 Gy).  A small fraction of cells could survive and these were cultured for at least 7 days 
to form separate colonies (two-dimensional cultures).  For a soft agar assay (three-
dimensional cultures), cells (1 x 104 in 6 cm dishes) uniformly suspended in 6 ml of 0.33% 
agarose gel with growth medium (DMEM supplemented with 5% FBS) were overlaid onto a 
base layer of 1% agarose gel equilibrated with growth medium.  After incubation for at least 
5 weeks, colonies developed in soft agar suspension were scored using phase-contrast 
microscopy by counting colony numbers under low magnification (x 100) in 10 separate 
arbitrary fields in each plate.  Cell clusters of more than approximately 100 m in diameter 
were defined as positive results. 
 
In vitro invasion assay and transmigration assay.  A cell suspension (5 x 105 in 0.5 ml of 
DMEM with 0.5% FBS) was added to 24-well cell culture inserts with 8 m pores (Becton 
Dickinson, Franklin Lakes, NJ) precoated with Matrigel (Invitrogen), while DMEM 
containing 10% FBS was added to the bottom chamber to create a chemotactic gradient.  
Invasive cells were measured after 48 h incubation at 37°C.  The bottom surface of the top 
chamber was wiped with cotton swabs, and cells that passed through the filters into the lower 
surface of the well were quantitated.  Similarly, transmigration assay through a rat lung 
endothelial cell (RLE) monolayer was done as described.(17)  Transmigrated viable cells on 
the lower surface of the transwell (8 m pores) were quantitated after harvesting the cancer 
cells on the endothelial monolayer for 24 h. 
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In vitro adhesion assay of the endothelial monolayer.  We performed adhesion assay of 
cancer cells in the media supplemented with 10% FBS with or without claudin-6-specific 
siRNA in the presence or absence of 1 M atRA.  MCF7 cells were transfected with a 
pEGFP-C1 vector (Invitrogen) to facilitate the fluorescent detection of adherent cells 48 h 
before the assay, and were overlaid onto an RLE endothelial monolayer.  After washing with 
PBS to remove nonadherent cells, cells with green signals were counted by fluorescent 
microscopy. 
 
Gelatin zymography.  The gelatinolytic activity of matrix metalloproteinases (MMPs) was 
determined in the supernatants of MCF7 cells treated with or without 1 M atRA for 24 h in 
the presence or absence of claudin-6 siRNA, using a standard protocol.  Clear bands appeared 
on the background in the areas of gelatinolytic activity. 
 
Methylation-specific PCR (MSP).  The methylation status of the promoter CpG islands of 
claudin-6 was analyzed by MSP on sodium bisulfite-converted DNA.(9,10,18)  Briefly, 2 µg of 
genomic DNA was denatured with 2 M NaOH for 10 min, followed by incubation with 3 M 
sodium bisulfite (pH 5.0) for 16 h at 50°C.  DNA was then precipitated with ethanol and 
resuspended in 20 µl of water.  Aliquots (2 µl) were used as templates for PCR.  The primers 
for MSP were as follows: 5’- AGGTGAGTTCCCCATGTCAC -3’ and 5’- 
CCGAAGGACCCTATCACCTC -3’ for the amplification of methylated alleles; 5’- 
TGTGAAGGTGGTTGGTGTGT -3’ and 5’- CCCACCCCATATTCATCCTA -3’ for the 
amplification of unmethylated alleles. 
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Statistical analysis.  Unless otherwise specified, all data represent the mean  SD of at least 
3 independent experiments, each in triplicate wells.  Statistical differences were analyzed 
using the paired t test, and were considered statistically significant when p<0.05. 
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Results 
 
Claudin-6 expression is partially suppressed by CpG island hypermethylation.  Aberrant 
promoter region CpG island hypermethylation is associated with transcriptional silencing of 
many genes in a wide variety of cancers.(19)  Our previous studies have demonstrated that the 
synergistic effect of a demethylator (5’Aza-dC) and HDAI (TSA) upregulates the expression 
of endogenous occludin, which eventually enhances the apoptotic sensitivity to various 
apoptogens.(9,10)  Therefore, we first examined whether treatment with the demethylator and 
HDAI altered the expression of other TJ-associated genes.  We found that treatment with 
5’Aza-dC and TSA could induce upregulation of a number of TJ-associated genes such as 
those of occludin, claudin-1, -2, and -6 (Fig. 1a).  The most striking effect by these agents 
was observed in the gene-expression alterations in claudin-6, in which claudin-6 mRNA was 
increased approximately 3-fold by treatment with 5’Aza-dC alone and 5-fold by the 
synergistic effect with 5’Aza-dC and TSA (Fig. 1b).  These agents did not change the 
expression of claudin-3, -4, or -7 (Fig. 1a), and the expression of claudin-5 and -8 was not 
observed in MCF7 cells (data not shown).  These findings suggested that claudin-6 
expression was preferentially suppressed by CpG island hypermethylation in MCF7 cells. 
 According to a search of a genome database, CpG islands exist in the promoter region 
of human claudin-6.  We then performed MSP analysis of MCF7 cells and found that CpG 
islands in the claudin-6 promoter were strongly methylated (Fig. 1c).  However, MCF7 cells 
were partially unmethylated in this region (Fig. 1c) and, as a result, an appreciable amount of 
endogenous claudin-6 expression was detected (Fig. 1a, 2a). 
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Decreased expression of claudin-6 provides apoptotic resistance in MCF7 cells.  It has 
been documented that claudin-6 is preferentially expressed in mammary epithelial cells and 
that the expression of claudin-6 is decreased in mammary cancer cell lines and breast cancer 
sample compared to normal breast tissue.(15)  We also found that the promoter region of 
claudin-6 was densely methylated in MCF7 cells (Fig. 1c).  To examine the functional role of 
claudin-6 in MCF7 cells, we determined the differential sensitivity of apoptosis to 24 h 
exposure to H2O2, which is a common cell stressor used to induce apoptosis.(9,16)  Prior to the 
apoptotic stimulation, the cell medium was changed to one without FBS supplementation and 
cells were exposed to the apoptogens.  Preliminary experiments confirmed that a wide range 
of concentrations of siRNA could effectively suppress endogenous claudin-6 expression (Fig. 
2a, 2b).  Treatment with atRA clearly enhanced the sensitivity to H2O2-induced cell death in 
dose- and time-dependent manners, whereas knockdown of claudin-6 expression provided 
significant resistance to apoptosis (Fig. 2c,left panel, and Fig. 2d).  We further employed the 
TUNEL assay and showed that with decreased expression of claudin-6 the sensitivity to 
H2O2-induced cell death was suppressed (Fig. 2c, right panel), which was coincident with the 
results of our assay (Fig. 2c, left panel).  On the other hand, manual cell counting every 24 h 
up to day 6 after plating equal numbers of cells showed no significant differences in the cell 
proliferation and DNA synthesis rates (Fig. 2e).  We next determined whether the suppressive 
role due to loss of claudin-6 was applicable to other apoptogenic stimuli, including oxidative 
stress, heat shock, genotoxic agents, and -irradiation.  Decreased expression of claudin-6 
also resulted in appreciable inhibition of apoptotic cell death against these stimuli (Fig. 2f), 
suggesting that the protective role of claudin-6 against apoptosis could be observed following 
exposure to a broad range of cell stressors.  These observations suggested that claudin-6 
expression modulated the apoptotic sensitivity of the cells. 
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 We could not examine the function of TJs of MCF7 cells because this cell line did not 
form a uniformly flat epithelial monolayer sheet on the semipermeable membrane support.  
Nor did we observe any morphological alterations in the course of the experiment when 
claudin-6 expression was induced or suppressed in the MCF7 cells (data not shown). 
 
Decreased expression of claudin-6 inhibits anoikis.  Evasion of and resistance to apoptosis 
are characteristic of cancer, and breakdown of anoikis may be a predominant contributor to 
oncogenic progression.(20,21)  We therefore examined whether siRNA-mediated knockdown of 
claudin-6 expression inhibited anoikis in MCF7 cells.  DNA fragmentation analysis 
demonstrated that decreased expression of claudin-6 clearly showed the limited sensitivity to 
anoikis (Fig. 3a).  TUNEL assay also revealed that atRA increased the sensitivity to anoikis 
in MCF7 cells, whereas siRNA-mediated knockdown of claudin-6 expression resulted in 
resistance to anoikis even in the presence of atRA (Fig. 3b).  Suppression of endogenous 
claudin-6 expression in MCF7 cells provided significant resistance to H2O2-induced 
apoptosis and anoikis, causing significant promotion of colony formation in two- and three-
dimensional cultures (Fig. 3c).  Since claudin-6 siRNA was transfected transiently in this 
experiment, it was clear that endogenous expression of claudin-6 was increased with cell 
division.  We should note here that MCF7 cells required 24 h for maximum reduction of 
claudin-6 after being transfected with claudin-6-specific siRNA, and significant suppression 
of claudin-6 was observed for 5 days (Fig. 3d).  This suggested that the colony formation was 
primarily determined by the sensitivity to apoptosis within a few days after plating for cell 
culture, in which significant suppression of claudin-6 expression was observed by siRNA 
transfection. 
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Methylator phenotype of claudin-6 promotes anchorage-independent growth.  We next 
examined whether the observed phenotypes induced by 5’Aza-dC/TSA treatment were due to 
enhanced expression of endogenous claudin-6, because 5-Aza-dC/TSA treatment leads to the 
derepression of a large number of genes.(18,19)  In MCF7 cells, either 5’Aza-dC alone and a 
synergistic effect with 5’Aza-dC and TSA was sufficient for apoptotic sensitization (Fig. 4a) 
and for suppression of colony forming capabilities in two- (Fig. 4b, left panel) and three-
dimensional cultures (Fig. 4b, right panel).  Importantly, claudin-6-specific siRNA 
significantly abrogated these effects, being possible to link the induction of endogenous 
claudin-6 with the observed phenotypes mediated by 5’Aza-dC/TSA.  In addition, double 
knockdown of claudin-6 and occludin had marked effects on apoptosis (Fig. 4a) and colony-
forming efficacy (Fig. 4b), when compared with the cells transfected only with claudin-6-
specific siRNA.(9,10)  Negative control siRNA had no effect on the cells during the course of 
the experiment (data not shown).  These observations suggested that epigenetic silencing of 
claudin-6 may partially but significantly contribute to enhanced anchorage-independent 
growth of cancer cells. 
 
Claudin-6 decreases invasiveness and transmigration through endothelial monolayer.  
To determine whether claudin-6 expression in cancer cells had a causal role in its invasive 
and transmigrative properties, we performed a Boyden chamber invasion assay and a 
transmigration assay through an endothelial monolayer.  We found that with decreased 
expression of claudin-6 invasive and transmigrative capacities of MCF7 cells were 
significantly increased, when compared with the control cells (Fig. 5a, 5b).  A gelatin 
zymogram for MMP activation also demonstrated that claudin-6 knockdown resulted in an 
increase in MMP activity and efficiently abrogated atRA-mediated downregulation of MMP 
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activity (Fig. 5c).  In addition, transfection with claudin-6-specific siRNA increased adhesion 
to the endothelial cells, which is known to be critical step for cancer cells to form a distant 
metastasis (Fig. 5d).  These data suggested that loss of claudin-6 expression was potentially 
associated with the invasive and transmigrative phenotypes of cancer cells. 
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Discussion 
 
 We have demonstrated that the methylator phenotype of occludin favors multiple 
steps known to be important in tumorigenesis, identifying occludin as a likely tumor 
suppressor gene in certain types of cancer.(9,10)  Similarly, this study was undertaken to 
understand the biological significance of altered claudin-6 expression in breast cancer.  We 
found that epigenetic silencing of claudin-6 expression potentially contributed to the highly 
tumorigenic and invasive properties of MCF7 breast carcinoma cells. 
 Promoter CpG island hypermethylation is an important means to epigenetically 
silence a particular gene associated with a carcinogenic step at the transcriptional level.(19)  
Our results showed that claudin-6 expression was partially but significantly inactivated by 
aberrant CpG island DNA hypermethylation in its promoter region.  The impact of our 
findings on breast cancer might be limited since the silencing of claudin-6 by DNA 
methylation was only shown in one breast cancer cell line, MCF7, and the loss of claudin-6 
expression has not been demonstrated to occur during human breast cancer progression.  
However, the expression of claudin-6 in mammary epithelial cells has been shown to be 
decreased in a different number of mammary cancer cell lines and breast cancer sample 
compared to normal breast tissue.(15)  Consistent with this finding, our observations indicate 
the importance of claudin-6 as at least a partial regulator of breast carcinogenesis. 
 It is now clear that claudin is a main constituent of TJs, whereas it has been shown 
that certain TJ-associated proteins directly associate with different signal transduction 
molecules that have functions in receiving or transmitting signals such as atypical protein 
kinase C and Rho proteins, and participate in the control of gene expression via the 
modulation of transcription machinery in the nucleus, implying that TJ-associated molecules 
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are signal transmitters located at TJs.(1-3)  Other TJ proteins also associate with Fos, Jun, 
CCAAT/enhancer binding protein, and activator protein-1, demonstrating that TJs have a 
direct functional association with a variety of signal transduction pathways.(1-3)  Considering 
this view, the possible mechanisms of observed phenotypes mediated by the decreased 
expression of claudin-6 in breast cancers might be primarily explained by signal transduction 
from membrane-anchored claudin-6 to the nucleus, and eventually claudin-6 might have 
direct associations with a different type of signaling molecule in the cells.  It is thus 
reasonable to believe that the certain TJ-associated genes such as claudin-6 and occludin may 
be committed to identical signaling pathways and have functional links under the control of 
common signaling components in the cells, since we observed similar effects on the cancer 
phenotype when the expression of either occludin and claudin-6 was suppressed.  This 
explanation is also supported by the evidence that tyrosine residues located at the carboxyl-
terminal are conserved among at least 8 claudin family members, claudin-1-8, and occludin.  
Although claudin-4 is, for example, a substrate for EphA2 receptor tyrosine kinase,(22) other 
claudins have the potential to be phosphorylated by EphA2 due to structural homology 
between the TJ-associated molecules.  Since EphA2 is frequently overexpressed in a variety 
of cancers, including breast cancers, and is a direct transcriptional target of the Ras-Raf-
mitogen-activated protein kinase pathway,(23,24) it is thus possible that the cellular 
transformation crucial for the progression of cancer is associated with the phosphorylation of 
different types of claudins, which are regulated by indistinguishable signals.  The tyrosine 
phosphorylation of TJ-associated proteins dissociates submembrane components of TJs, and 
causally decreases integration of claudins into sites of cell-cell contact, consistent with the 
well-accepted concept that oncogenic transformation during carcinogenesis is accompanied 
by a disruption of TJs. 
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 Our previous studies have demonstrated that epigenetic silencing of occludin results 
in cellular resistance to apoptogenic stimuli and is involved in the cellular senescence-escape 
program, consequently contributing to the enhanced tumorigenic, invasive, and metastatic 
properties of cancer cells.(9,10)  However, it is clear that apoptotic resistance, increased cell 
migration, and cell adhesion to endothelial cells are basically different and functionally 
separate cellular events.  Given the extensive range of physiological activities of TJs and the 
functional diversity of TJ-associated genes, it is not surprising that TJ-associated molecules 
such as claudin-6 affect various cellular functions in a given cell.  Alternatively, there may be 
other as yet unidentified signaling in the cells that is activated and modulated by claudin-6.  
No direct proof exists to support this possibility, and we cannot presently determine whether 
claudin-6 has specific effects on the cells when compared with the other types of claudins. 
 On the other hand, several studies have confirmed the paradoxical upregulation of 
claudins in various cancers derived from the breast, stomach, pancreas, and ovary.(25,26)  In 
addition, certain types of claudins have been shown to modify tumor invasion by regulation 
of MMP activity, suggesting the potential involvement of claudins in invasion and metastasis 
of cancer cells.(27,28)  Although the functional importance of claudins in cancers has been 
suggested by a number of studies, future studies should address the underlying mechanisms 
by which certain TJ proteins determine the progressiveness of cancer cells. 
 It has been postulated that the formation of TJs reduces the highly tumorigenic 
phenotype of cancer cells.  A number of reports have shown that the overexpression of TJ-
associated genes confers less tumorigenic and invasive phenotypes in vivo, accompanied by 
an increase in TJs between cell boundaries in certain claudin-overexpressing cells.(7,8)  These 
observations lead to the conclusion that TJ protein in cancer cells forms diffusion barriers and 
restricts the access of nutrients and growth factors inside the cell aggregates, and that an 
 18
increase in TJ-based cell-cell adhesion may inhibit the dissociation of cancer cells from the 
primary tumor.  We can exclude the former proposed mechanism because we observed 
significantly different cell death sensitivities even in adherent cells.  Interestingly, it is 
interesting to propose the novel strategy that cell-cell adhesion formed by TJs may suppress 
the invasiveness into cancer-surrounding tissue and the formation of distant metastases. 
 Our present study raises the possibility of developing claudin-6 as a potential 
biomarker and as a promising candidate for therapy that would abrogate the highly 
tumorigenic phenotype of breast cancer.  Because of the high specificity of claudin 
expression patterns in cancer, claudins may act as useful molecular markers and prognostic 
indicators for many different cancers.  We believe that certain TJ proteins may not only 
represent promising targets for tumor detection and diagnosis, but also provide new 
opportunities for therapeutic intervention. 
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Figure legends 
 
Figure 1.  Claudin-6 expression is epigenetically silenced by CpG island promoter 
hypermethylation.  (a) Quantitative RT-PCR analysis to examine the changes of TJ-
associated genes in MCF7 cells after culture with vehicle (lane 1), 5’Aza-dC (lane 2), and 
5’Aza-dC/TSA (lane 3).  (b) Quantitative analysis of the gene expression of occludin and 
claudin-6 for independent triplicate experiments, as examined in (a).  The cells treated with 
vehicle were used as a control, and gene expression in these cells was defined as 100%.  (c) 
MSP analysis to detect the unmethylated (UM) and methylated (M) alleles on CpG islands of 
the claudin-6 promoter.  *, p<0.05, vs. cells with vehicle treatment. 
 
Figure 2.  Knockdown of claudin-6 provides cellular resistance to apoptosis in MCF7 cells.  
(a) Gene-expression alteration of claudin-6 after transfection with various concentrations of 
claudin-6-specific siRNA.  Densitometric analyses for independent triplicate experiments are 
shown below the representative image.  The signal of claudin-6 without the transfection was 
defined as 100%.  (b) Western blot analysis confirmed the silencing effect of siRNA targeted 
to claudin-6 (+: 25 nM).  (c) Left panel, cell death mediated by various concentrations of 
H2O2 after 24 h in the presence or absence of atRA with or without claudin-6-specific siRNA 
(Cl-6) transfection.  Right panel, TUNEL assay to confirm the type of cell death and cell 
death rates after 24 h with or without claudin-6-specific siRNA transfection in the presence of 
100 M H2O2.  Negative control siRNA (Neg) had no effect on the cells.  (d) Cell death in 
the presence (open symbol and dotted line) or absence (closed symbol and solid line) of atRA 
at the indicated time points up to 24 h in the presence of 100 M H2O2 in combination with 
(circle) or without (square) claudin-6-specific siRNA transfection.  (e) Cell proliferation 
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assay with (open symbol) or without (closed symbol) claudin-6-specific siRNA transfection 
for up to 6 days.  Insets show the Ki67 labelling indices at day 6.  (f) Cell death was 
quantitated after 24 h in the presence or absence of claudin-6-specific (Cl-6) or negative 
control (Neg) siRNA transfection with various death stimuli.  Lane 1, H2O2 (100 M); lane 2, 
cisplatin (10 g/ml); lane 3, etoposide (50 M); lane 4, heat shock at 42C for 30 min; lane 5, 
-irradiation (50 Gy); lane 6, -irradiation (100 Gy).  *, p<0.05, vs. cells without atRA 
treatment; #, p<0.05, vs. cells without claudin-6 siRNA transfection. 
 
Figure 3.  Decreased expression of claudin-6 enhances colony-forming efficacy in MCF7 
cells.  (a, b) Anoikis was induced after adding cells to agarose-coated dishes to avoid cell 
attachment.  DNA laddering analysis to confirm apoptotic cell death (a).  Quantification of 
anoikis in the presence or absence of atRA with or without claudin-6-specific (Cl-6) or 
negative control (Neg) siRNA transfection (b).  (c) Knockdown of claudin-6 expression 
promotes colony formation in two- (left panel) or three-dimensional (right panel) cultures.  
The number of colonies formed from control cells was defined as 100%.  (d) Quantitative 
RT-PCR analysis confirmed the silencing effect of claudin-6-specific siRNA during the 
course of the experiment.  Densitometric analyses for independent triplicate experiments are 
shown below the representative image.  The signal of claudin-6 was defined as 100% in 
MCF7 cells without the transfection.  *, p<0.05, vs. cells without atRA treatment; #, p<0.05, 
vs. cells without claudin-6 siRNA transfection. 
 
Figure 4.  Epigenetic silencing of claudin-6 provides resistance to apoptosis and promotes 
anchorage-independent growth in MCF7 cells.  (a) Endogenous expression of claudin-6 
induced by 5’Aza-dC alone or synergy with 5’Aza-dC and TSA is sufficient for apoptotic 
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sensitization.  siRNA-mediated knockdown of claudin-6 (Cl-6) expression decreases 
apoptotic sensitivity, and double knockdown of claudin-6 (Cl-6) and occludin (Oc) 
synergistically enhances the anti-apoptotic effect.  (b) Colony forming efficacy after either 
5’Aza-dC alone or 5’Aza-dC and TSA treatment in two-dimensional (left panel) and three-
dimensional (right panel) cultures.  The number of colonies formed from control cells without 
the treatment was defined as 100%.  *, p<0.05, vs. cells without either 5’Aza-dC alone or 
5’Aza-dC/TSA treatment; #, p<0.05, vs. cells without either claudin-6 siRNA alone or 
claudin-6 and occludin siRNA transfection. 
 
Figure 5.  Suppression of claudin-6 expression increases cellular invasion and transmigration 
through an endothelial monolayer.  (a) Decreased expression of claudin-6 enhances invasive 
capacity in MCF7 cells, as assessed by Boyden chamber invasion assay using Matrigel matrix 
(left panel), and its quantitative analysis of invading cells transfected with (+) or without (-) 
claudin-6-specific (Cl-6) or negative control (Neg) siRNA (right panel).  Scale bar, 200 m.  
(b) Transmigration assay in MCF7 cells that transmigrated through an endothelial monolayer, 
transfected with (+) or without (-) claudin-6-specific siRNA.  (c) Gelatin zymography for 
determination of MMP activity in the presence or absence of atRA with or without claudin-6 
siRNA transfection.  The signals of MMP-2 (lower band) are quantiatated for MMP activities 
and are defined as 100% in MCF7 cells without the treatment and transfection.  (d) Adhesion 
assay of cancer cells with (filled square and solid line) or without (filled circle and dotted 
line) claudin-6-specific siRNA transfection to a monolayer of endothelial cells in the 
presence (right panel) or absence (left panel) of 1 M atRA.  *, p<0.05, vs. cells without 
atRA treatment; #, p<0.05, vs. cells without claudin-6 siRNA transfection. 





